0000950170-24-007936.txt : 20240126
0000950170-24-007936.hdr.sgml : 20240126
20240126161511
ACCESSION NUMBER: 0000950170-24-007936
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240125
FILED AS OF DATE: 20240126
DATE AS OF CHANGE: 20240126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewicki John A.
CENTRAL INDEX KEY: 0001553352
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38452
FILM NUMBER: 24567916
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mereo BioPharma Group plc
CENTRAL INDEX KEY: 0001719714
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
BUSINESS PHONE: 4403330237300
MAIL ADDRESS:
STREET 1: ONE CAVENDISH PLACE
STREET 2: FOURTH FLOOR
CITY: LONDON
STATE: X0
ZIP: W1G0QF
FORMER COMPANY:
FORMER CONFORMED NAME: Mereo Biopharma Group plc
DATE OF NAME CHANGE: 20171016
4
1
ownership.xml
4
X0508
4
2024-01-25
0001719714
Mereo BioPharma Group plc
MREO
0001553352
Lewicki John A.
C/O MEREO BIOPHARMA GROUP PLC
4TH FLOOR, ONE CAVENDISH PLACE
LONDON
X0
W1G 0QF
UNITED KINGDOM
false
true
false
false
Chief Scientific Officer
false
Share Options (Right to buy)
3.36
2024-01-25
4
A
false
137000
0.00
A
2034-01-25
American Depository Shares
137000
137000
D
25% of the shares underlying this share option will vest and become exercisable on January 25, 2025, with the remainder vesting in equal monthly installments for the three years thereafter.
Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
/s/ Christine Fox, by power of attorney
2024-01-26